Last updated 2026-09-04
- Went public on NASDAQ (CMND), Nov 2022
- Signs LOI to acquire 51% stake in EV wireless charging company, Aug 2026
- Raised $7.5M Follow-on PO, Nov 2022
Total raised
$21.2M
Last: Convertible Debt 2025-09
Stage
Public
Founded
2017
Headcount
2
HQ
Tel Aviv-Yafo, Israel
Sector
Healthcare
About
Clearmind Medicine Inc. is a clinical-stage pharmaceutical biotechnology company focused on the discovery and development of novel psychedelic-derived therapeutics for widespread and underserved health problems, including alcohol use disorder, binge eating, depression, anxiety disorders, post-traumatic stress disorder, and treatment-resistant depression. The company's primary objective is to research and develop psychedelic-based compounds and commercialize them as regulated medicines, foods, or supplements. While headquartered in Vancouver, Canada, its R&D activities are conducted in Israel, and it has an office in Tel Aviv.
Funding history · 5 rounds · $21.2M total
8 events/rounds · $21.2M Total Funding: $6.2M in Private Equity, $28.4M in Public Equity
Dec 2025
Follow-on PO
$1.6M
EDGAR filing SEC-EDGAR filing SEC-EDGAR
Sep 2023
Follow-on PO
$2.4M
EDGAR filing SEC-EDGAR filing SEC-EDGAR
Apr 2023
Follow-on PO
$3.5M
EDGAR filing SEC-EDGAR filing SEC-EDGAR
Nov 2022
Follow-on PO
$7.5M
EDGAR filing SEC-EDGAR filing SEC-EDGAR
Apr 2021
★ former CFO★ one director★ one 5% holder★ Certain investors★ one of Clearmind's directors★ one of Clearmind's 5% holders★ Clearmind's former Chief Financial Officer
Headcount over time
2 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Show all offices (1 more)
- Vancouver, Canada
Q&A
- What is Clearmind Medicine's primary focus?
- Clearmind Medicine Inc. is a clinical-stage pharmaceutical biotechnology company focused on the discovery and development of novel psychedelic-derived therapeutics for widespread and underserved health problems, including alcohol use disorder, binge eating, depression, anxiety disorders, post-traumatic stress disorder, and treatment-resistant depression.
- Where are Clearmind Medicine's R&D activities conducted?
- While headquartered in Vancouver, Canada, Clearmind Medicine's R&D activities are conducted in Israel, and it has an office in Tel Aviv.
- What is the company's employee count?
- Clearmind Medicine has 1-10 employees.
- When did Clearmind Medicine become a public company?
- Clearmind Medicine went public on the CSE in June 2022 and on NASDAQ in November 2022.
- What was the amount raised in Clearmind Medicine's Public Offering in November 2022?
- In November 2022, Clearmind Medicine raised $7,500,005.5 in a Public Offering.
- What was the amount raised in Clearmind Medicine's Public Offering in April 2023?
- In April 2023, Clearmind Medicine raised $3,514,460 in a Public Offering.
- What was the amount raised in Clearmind Medicine's Public Offering in September 2023?
- In September 2023, Clearmind Medicine raised $2,250,000 in a Public Offering.
- What was the amount raised in Clearmind Medicine's Public Offering in January 2024?
- In January 2024, Clearmind Medicine raised $2,400,000 in a Public Offering.
- What was the amount of Clearmind Medicine's Convertible Debt round in September 2025?
- In September 2025, Clearmind Medicine secured $10,000,000 in a Convertible Debt round.
- What is the company's market capitalization?
- Clearmind Medicine has a market capitalization of $5,298,975.
Team · 17
Adi Zuloff-Shani
Chief Executive Officer
Alan Rootenberg
Chief Financial Officer
Mark Haden
VP Business Development
Gadi Levin
VP Finance
Sara Horn
Clinical and Regulatory Affairs
Mary-Elizabeth Gifford
Chief of Global Impact
Amit Shwartz
R&D Consultant
Nicholas Kadysh
Special Advisor, Alcohol Substitute Program
Shannon Smadella
Special Advisor, Strategy and Communication
Yael Stav
Program Management
Mylene Touboul
Accounting Manager
Adi Varon
Controller
Amitay Weiss
Chairman of the Board
Oz Adler
Director
Yehonatan Shachar
Director
Asaf Itzhaik
Director
Hila Kiron-Revach
Chairperson of the Board
Sectors & technology
Primary sector
Healthcare
Technologies
Target customers
Business model
B2C
Highlights
1 Patents
Tags
drug-discoverymental-healthpharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | clearmindmedicine.com/ |
|---|---|
| linkedin.com/company/77869104 | |
| facebook.com/ClearmindMedicine | |
| YouTube | youtube.com/channel/UCg_JDmUZSqstavsbd3zYmmg |
Identifiers & details
| Legal name | Clearmind Medicine Inc. |
|---|---|
| Founded | 2017-7 |
| Employees (exact) | 2 |
| Offices | Vancouver |
| Market cap | $5.3M |
| Status reason | Public on CSE on Jun 2022;Public on NASDAQ on Nov 2022; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2022-11 | NASDAQ | CMND | $7.5M |
| Public Offering | 2023-04 | NASDAQ | CMND | $3.5M |
| Registered Direct Offering | 2024-01 | NASDAQ | CMND | $2.4M |
Radar intelligence
Patents
| EPO | 15 |
|---|
Web history (Wayback)
| Domain | clearmindmedicine.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516397759 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-05-19 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ולנברג ראול 20 תל אביב - יפו |